Back to Search
LEE CICCARELLI, M.D.
M.D.
Specialist
NPI: 1417909029IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
MD022616E(PA)
Legal Medicine
Legal Medicine
Code: 173000000X
MD022616E(PA)
Education
WAKE FOREST UNIVERSITY SCHOOL OF MEDICINE
Class of 1978
Research & Publications (20)
Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study.
PMID 19267581·Diabetes Technol Ther·2009
8-other
Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire.
PMID 19622510·Ann Oncol·2009
4-observational
Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment.
PMID 19650249·J Clin Pharm Ther·2009
3-trial
Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.
PMID 19252346·Intern Med·2009
4-observational
What is the correlation of in vivo wear and damage patterns with in vitro TDR motion response?
PMID 18317190·Spine (Phila Pa 1976)·2008
8-other
Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin.
PMID 18375253·Arch Med Res·2008
4-observational
Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin.
PMID 17587750·Hypertens Res·2007
4-observational
Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin.
PMID 17229249·Intern Med J·2007
4-observational
Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
PMID 17345784·Hypertens Res·2006
4-observational
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial.
PMID 16448524·Diabetes Obes Metab·2006
4-observational
Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance.
PMID 17163286·Clin Drug Investig·2006
4-observational
Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients.
PMID 16896785·Eur J Clin Pharmacol·2006
2-rct
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.
PMID 16882108·J Clin Pharm Ther·2006
4-observational
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
PMID 16861090·Clin Ther·2006
4-observational
Effect of doxazosin on C-reactive protein plasma levels and on nitric oxide in patients with hypertension.
PMID 16680063·J Cardiovasc Pharmacol·2006
3-trial
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.
PMID 15899724·Pharmacotherapy·2005
3-trial
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride.
PMID 16555581·Hypertens Res·2005
3-trial
Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
PMID 16291411·Clin Ther·2005
3-trial
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome.
PMID 15955382·Diabetes Res Clin Pract·2005
3-trial
Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension.
PMID 15897788·J Cardiovasc Pharmacol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 429 WASHINGTON BLVD
WILLIAMSPORT, PA 17701 - Phone
- (570) 327-9480
Quick Facts
- NPI
- 1417909029
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 48
- Publications
- 20
Are you this provider?
Claim Your Profile